product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human VEGF-C DuoSet ELISA
catalog :
DY752B
quantity :
1 Kit (for 15 Plates)
price :
850 USD
more info or order :
citations: 13
Reference
Shams S, Stilhano R, Silva E. Harnessing EGLN1 Gene Editing to Amplify HIF-1α and Enhance Human Angiogenic Response. bioRxiv. 2023;: pubmed publisher
Jiang J, Cong X, Alageel S, Dornseifer U, Schilling A, Hadjipanayi E, et al. In Vitro Comparison of Lymphangiogenic Potential of Hypoxia Preconditioned Serum (HPS) and Platelet-Rich Plasma (PRP). Int J Mol Sci. 2023;24: pubmed publisher
Ding Y, Oliveira Ferrer L, Vettorazzi E, Legler K, Milde Langosch K, Woelber L, et al. VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients. PLoS ONE. 2022;17:e0269680 pubmed publisher
Lapuente J, Bl xe1 zquez Mart xed nez A, Marco Brualla J, G xf3 mez G, Desportes P, Sanz J, et al. Cytokine Profile and Anti-Inflammatory Activity of a Standardized Conditioned Medium Obtained by Coculture of Monocytes and Mesenchymal Stromal Cells (PRS CK STORM). Biomolecules. 2022;12: pubmed publisher
Cristinziano L, Poto R, Criscuolo G, Ferrara A, Galdiero M, Modestino L, et al. IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. Cells. 2021;10: pubmed publisher
Varricchi G, Loffredo S, Bencivenga L, Ferrara A, Gambino G, Ferrara N, et al. Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2 in Ischemic and Non-Ischemic Heart Failure. J Clin Med. 2020;9: pubmed publisher
Varricchi G, Loffredo S, Borriello F, Pecoraro A, Rivellese F, Genovese A, et al. Superantigenic Activation of Human Cardiac Mast Cells. Int J Mol Sci. 2019;20: pubmed publisher
Ndiaye P, Dufies M, Giuliano S, Douguet L, Grepin R, Durivault J, et al. VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness. Theranostics. 2019;9:661-675 pubmed publisher
Bourland J, Fradette J, Auger F. Tissue-engineered 3D melanoma model with blood and lymphatic capillaries for drug development. Sci Rep. 2018;8:13191 pubmed publisher
Lupu Plesu M, Claren A, Martial S, N Diaye P, Lebrigand K, Pons N, et al. Effects of proton versus photon irradiation on (lymph)angiogenic, inflammatory, proliferative and anti-tumor immune responses in head and neck squamous cell carcinoma. Oncogenesis. 2017;6:e354 pubmed publisher
Kumar N, Moideen K, Sivakumar S, Menon P, Viswanathan V, Kornfeld H, et al. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors. J Infect. 2017;74:10-21 pubmed publisher
Kumar N, Banurekha V, Nair D, Babu S. Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis. PLoS ONE. 2016;11:e0146318 pubmed publisher
Grepin R, Guyot M, Giuliano S, Boncompagni M, Ambrosetti D, Chamorey E, et al. The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma. Cancer Res. 2014;74:873-83 pubmed publisher
image
image 1 :
R&D Systems DY752B image 1
Human VEGF-C ELISA Standard Curve
product information
master code :
DY752B
SKU :
DY752B
product name :
Human VEGF-C DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human VEGF-C DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human VEGF-C.
target :
VEGF-C
category :
ELISAs
species :
Human
gene symbol :
VEGFC
kit type :
Solid Phase Sandwich ELISA
elisaRange :
62.50 - 4000 pg/mL
top caption :
Human VEGF-C ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
Flt4 ligand, Flt4-L, vascular endothelial growth factor C, Vascular endothelial growth factor-related protein, VEGFC, VEGF-C, VRPFLT4 ligand DHM
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.